Loading…
LANXESS agreed on August 23, 2021 to acquire IFF's microbial control business for about US$450 million in sales, with closing expected in Q2 2022. The article also references progress on Xinhecheng's methionine project.
The deal is a specialty chemicals acquisition with little direct effect on feed commodity supply or prices, though the methionine project mention has limited relevance to feed amino acid markets.
echemi.comAug 30, 2021Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
